We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Siemens and Biosense Webster Extend Catheter Distribution Agreement

By MedImaging staff writers
Posted on 02 Feb 2007
Siemens Medical Solutions (Erlangen, Germany) and Biosense Webster, Inc. More...
(Diamond Bar, CA, USA) announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' Acuson AcuNav ultrasound catheters to interventional cardiologists.

Earlier in 2007, Biosense Webster was granted exclusive distribution rights to market the catheter to electrophysiologists. The Siemens AcuNav ultrasound catheters provide physicians with high-quality diagnostic images and Doppler blood flow data throughout the entire heart during a cardiac catheterization procedure. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products, will help physicians improve care for the cardiac patient,” said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA). "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community.”

Biosense Webster is a major player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader. This expanded strategic alliance will enable both two companies to address the real-time imaging needs of interventional cardiologists.

"We are pleased to extend this strategic alliance with Siemens Medical Solutions Ultrasound Division into the interventional cardiology market. This agreement provides additional opportunities to collaborate with our partners at Siemens to bring to market innovative solutions in electrophysiology and interventional cardiology,” said Roy Tanaka, president, Biosense Webster. "Together, Biosense Webster and Siemens will better serve the needs of cardiologists around the world to help millions of patients each year who suffer from cardiovascular disease.”

Biosense Webster pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to provide advanced diagnostic, therapeutic, and mapping tools.



Related Links:
Siemens Medical Solutions
Biosense Webster

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.